Drugs / metformin eicosapentaenoate
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02113163 Comparator | Mar → Jun 2014 | hypertriglyceridemia, type 2 diabetes mellitus | Thetis Pharmaceuticals LLC | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | metformin eicosapentaenoate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02113163 ↗ |
| Known as | TP-101 | “metformin eicosapentaenoate or TP-101” NCT02113163 ↗ |